WHO
By
WHO
Published: July 1, 2013, 10:51 a.m.·
Tags:
None
Threshold for starting treatment raised to CD4 count of 500. The Organization continues to recommend that all people with HIV with active TB receive antiretroviral therapy irrespective of CD4 cell count.
Read More →
By
WHO
Published: June 13, 2013, 8:23 p.m.·
Tags:
None
The interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the programmatic management of drug-resistant TB (2011 Update).
Read More →
By
ERS,
WHO
Published: June 12, 2013, 7:25 p.m.·
Tags:
None
The ERS and WHO will now provide scientifically sound and evidence-based advice, and clinical consultation through the Internet to national consiliums and individual practitioners on the management of MDR-TB and other difficult-to-treat TB cases, including TB/HIV and paediatric cases.
Read More →
By
WHO
Published: Jan. 16, 2013, 5:19 p.m.·
Tags:
None
Following a technical consultation held between the World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC) in Atlanta, GA, in September 2008 on strategies, approaches and partnerships that could be implemented to improve laboratory biosafety worldwide, an Expert Group meeting was convened at WHO’s Headquarters in Geneva, Switzerland, in April 2009 to elaborate guidance on biosafety related to laboratory procedures for diagnosing
tuberculosis (TB). The purpose of the meeting was to reach consensus on the basic principles of laboratory practices and design necessary to establish minimum criteria to ensure biosafety during TB microscopy, culture, drug-susceptibility testing (DST) and molecular testing in different countries and epidemiological settings.
Read More →
By
WHO
Published: July 10, 2012, 10:52 a.m.·
Tags:
None
Every year, millions of patients in resource-limited countries receive life-saving medicines that are purchased by or through international procurement agencies such as UNICEF, UNFPA, UNITAID and the Global Fund to Fight AIDS, TB and Malaria. The WHO Prequalification of Medicines Programme ensures that selected medicines supplied by these agencies meet international standards of quality, safety and efficacy.
Read More →
By
WHO
Published: March 24, 2012, 9:59 a.m.·
Tags:
None
There is currently insufficient evidence to adopt new case definitions for drug-resistant TB.
Read More →
By
WHO
Published: March 22, 2012, 4:56 p.m.·
Tags:
None
Childhood TB is a hidden epidemic
Read More →
Page 2 of 2 · Total posts: 7
←First
1
2